Publications found:
54,468
Sort by:
Asia - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast
US$ 1,100.00
... in order to achieve a specific level of glycemic control and to prevent hypoglycemia. Self-monitoring of blood glucose is a very lucrative business with enormous market opportunity ... maximum share of the SMBG market. iGATE RESEARCH report titled “Asia - Self Monitoring of Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and ...
September 2016
123 pages
Global Blood Irradiation Sales Market by Manufacturers, Regions, Type and Application, Forecast to 2021
US$ 3,480.00
... the global Blood Irradiation Sales market. Chapter 1, to describe Blood Irradiation Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Blood Irradiation Sales, with sales, revenue ...
September 2016
115 pages
Analyzing the Global Diabetes Market 2016
US$ 1,000.00
... for diabetes are analyzed in this section. We also look at diabetes epidemiology. Moving to the next section, we analyze the global diabetes market through a market overview and an analysis of the market by diabetes ...
September 2016
195 pages
US Breast Cancer Drug Market Outlook 2022
US$ 1,800.00
... Breast Cancer Drug Market Outlook 2022” Report Highlights: US Breast Cancer Tendencies US Breast Cancer Drug Market Outline US Breast Cancer Drug Market Dynamics Breast Cancer Risk Undercurrents US Breast Cancer Marketed Drugs Clinical Insight by Company & Patent Analysis US Breast Cancer Marketed ...
September 2016
130 pages
Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022
US$ 5,540.00
... outlook of the market. Key market segments The world exosome diagnostic and therapeutic market is segmented into application, product, end user, and geography. MARKET BY APPLICATION Diagnostic Therapeutic MARKET BY PRODUCT Instrument ...
September 2016
115 pages
Ulcerative Colitis: KOL Insight
US$ 7,900.00
... UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
September 2016
-
Hepatitis C: KOL Insight
US$ 7,900.00
... options? Since the launch of Sovaldi (sofosbuvir; Gilead) in 2013, the hepatitis C (HCV) landscape has developed at a rapid pace. The focus has ... report reveals candid insights about the HCV landscape from 12 KOLs in North America and Europe. You’ll learn which treatments KOLs have confidence ... advantage. Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product ...
September 2016
-
Cancer/Tumor Profiling - Global Market Outlook (2016-2022)
US$ 4,150.00
... MRC, the Global Cancer/Tumor Profiling market is expected to grow from $23.04 billion in 2015 to reach $78.69 billion by 2022 with a CAGR of 19.2%. Increasing cases of cancer and the need ... cancer profiling industry leaders. Asia Pacific is expected to witness huge growth due to raising incidence of cancer in this region. Some of the key players in global Cancer/Tumor profiling market ...
September 2016
147 pages
Industrial Control And Factory Automation - Global Market Outlook (2016-2022)
US$ 4,150.00
According to Stratistics MRC, the Global Industrial Control and Factory Automation market is accounted for $138.56 billion in 2015 and is expected to reach $ ... India. Factory automation is increasing in China, due to the large number of automotive manufacturing plants. Some of the key players of the Industrial Control and Factory Automation market include ...
September 2016
134 pages
Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016
US$ 4,995.00
... 3 rival brands managed small barrier-related gains? Which barriers have the biggest impact on market share? Find out in Market Access Impact: NSCLC. Request sample pages ... ) Exploring Important Market Access Issues Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: What brands ...
September 2016
-
Market Access Impact: Non-Small Cell Lung Cancer (US) 2016
US$ 4,995.00
... barriers related to market access affect slightly more prescriptions than any other barrier. One brand has a small perception problem: 15% ... Exploring Market Access Barriers Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: ...
September 2016
-
Global Blood Plasma Market DataPack (2016-2020)
US$ 450.00
The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research. The market figures and ... also explores the competitive landscape of the respective market with focus on major players. The DataPack serves as a must read for anyone willing ...
August 2016
63 pages
2016 Italy Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,000.00
... unique report from VPGMarketResearch provides Italy sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
125 pages
2016 Japan Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,400.00
... unique report from VPGMarketResearch provides Japan sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
129 pages
2016 Spain Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,360.00
... unique report from VPGMarketResearch provides Spain sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
128 pages
2016 UK Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 2,080.00
... provides UK sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
124 pages
2016 US Cancer Diagnostic Testing Market: Sales and Market Shares of Major Suppliers by Assay
US$ 3,200.00
... provides US sales and market share estimates for major suppliers of cancer diagnostic testing products by assay and country. The report also presents strategic ... -Clinical Diagnostics Panacea Pharmaceuticals Polartechnics Polymedco PreMD Qiagen Quest Diagnostics Radient Pharmaceuticals Roche Scienion Sequenom Siemens Healthcare Takara Bio Targeted Diagnostics ...
August 2016
136 pages
